Translating symptoms into mechanisms: Functional GI disorders

American Journal of Physiology - Advances in Physiology Education

Volumn 31, Issue 4, 2007, Pages 329-331

  Collins, Stephen M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Bacteria; Constipation; Diarrhea; Irritable bowel syndrome; Motility; Pain

Indexed keywords

EID: 37249029557     PISSN: 10434046     EISSN: 15221229     Source Type: Journal    
DOI: 10.1152/advan.00058.2007     Document Type: Short Survey

References (28)

1. Azpiroz FF, Bouin MF, Camilleri MF, Mayer EA, Poitras PF, Serra JF, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 19: 62-88, 2007.
2. Bassotti GF, Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol 12: 4609-4613, 2006.
3. Cash BD, Chey W, Chey WD. Diagnosis of irritable bowel syndrome. Gastroenterol Clin North Am 34: 205-220, 2005.
4. Cash BF, Sullivan S, Barghout V, Barghout V. Total costs of IBS: employer and managed care perspective. Am J Manag Care 11: S7-S16, 2005.
5. Collins SM. The relationship of enteric microbial infection and functional bowel disorders. J Clin Gastroenterol 41, Suppl 1: S30-S32, 2007.
6. Crowell MD, Harris L, Harris LF, Jones MP, Chang L, Chang L. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep 7: 272-279, 2005.
7. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut 51, Suppl 1: i67-i71, 2002.
8. Farthing MJ. Functional diarrhea. Curr Gastroenterol Rep 7: 350-357, 2005.
9. Gudmand-Hoyer E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr 59: 735S-741S, 1994.
10. Hooper LV, Falk PG, Gordon JI. Analyzing the molecular foundations of commensalism in the mouse intestine. Curr Opin Microbiol 3: 79-85, 2000.
11. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 292: 1115-1118, 2001.
12. Lea RF, Whorwell PJ. Psychological influences on the irritable bowel syndrome. Minerva Med 95: 443-450, 2004.
13. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 292: 852-858, 2004.
14. Mach T. The brain-gut axis in irritable bowel syndrome-clinical aspects. Med Sci Monit 10: RA125-RA131, 2004.
15. Macpherson AJ, Harris N, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4: 478-485, 2004.
16. Malagelada JR. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Int J Clin Pract 60: 57-63, 2006.
17. Marshall JK, Thabane MF, Garg AX, Clark WF, Meddings JF, Collins SM. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 20: 1317-1322, 2004.
18. Maxion-Bergemann S, Thielecke F, Thielecke FF, Abel FF, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 24: 21-37, 2006.
19. Mayer EA, Naliboff B, Naliboff BD, Chang L, Chang L. Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment. Eur J Surg Suppl: 3-9, 2002.
20. Mulak AF, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 10: RA55-RA62, 2004.
21. Patel RP, Petitta A, Petitta AF, Fogel RF, Peterson E, Zarowitz B, Zarowitz BJ. The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 35: 14-20, 2002.
22. Quigley EM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis 8: 2-7, 2007.
23. Schwetz IF, Bradesi S, Mayer, Mayer EA. The pathophysiology of irritable bowel syndrome. Minerva Med 95: 419-426, 2004.
24. Spiller R. Role of motility in chronic diarrhoea. Neurogastroenterol Motil 18: 1045-1055, 2006.
25. Spiller RC. Potential future therapies for irritable bowel syndrome: will disease modifying therapy as opposed to symptomatic control become a reality? Gastroenterol Clin North Am 34: 337-354, 2005.
26. Tillisch KF, Chang L. Diagnosis and treatment of irritable bowel syndrome: state of the art. Curr Gastroenterol Rep 7: 249-256, 2005.
27. Tougas G. The nature of pain in irritable bowel syndrome. J Clin Gastroenterol 35: S26-S30, 2002.
28. Verdu EF, Bercik PF, Verma-Gandhu MF, Huang XX, Blennerhassett PF, Jackson WF, Mao YF, Wang LF, Rochat FF, Collins SM. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55: 182-190, 2006.